Respiratory Disorders Segment, by Indication, to Account for Largest Share in Enteral Medical Nutrition Market During 2022–2028
According to our latest study on “Enteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Indication, Nutrition Type, Form, Product, Distribution Channel, and Age Group,” the market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the enteral medical nutrition market is primarily attributed to the increase in prevalence of cachexia in patients and rise in prevalence of gastrointestinal diseases. However, the complications related to enteral nutrition hamper the market growth.
Based on indication, the enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The market for the respiratory disorders segment is further segmented into chronic obstructive pulmonary diseases, respiratory failure, cystic fibrosis, and others. In 2021, the respiratory disorders segment held the largest share of the market. The major factor driving the market growth for the segment is the increasing prevalence of respiratory diseases. As per the National Hospital Ambulatory Medical Care Survey: 2018, there were 873,000 number of visits to emergency departments due to COPD in the US. The enteral medical nutrition market for the cancer segment is further segmented into cancer cachexia, cachexia withh COPD, and others. The cancer segment is expected to register the highest CAGR during 2022–2028. The enteral medical nutrition market for the gastrointestinal disorders is subsegmented into bowel obstruction, Crohn’s disease, short bowel syndrome, and others.
- Based on nutrition type, the enteral medical nutrition market is bifurcated into supplemental and sole-source. The supplemental segment held a larger share of the market in 2021. However, the sole-source segment is anticipated to register a higher CAGR during the forecast period.
- Based on form, the enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period.
- Based on product, the enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2021. However, the fruit juice based oral nutritional supplement segment is anticipated to register the highest CAGR during the forecast period.
- Based on distribution channel, the enteral medical nutrition market is segmented into hospital pharmacies, retail stores, and other pharmacies. The hospital pharmacies segment held the largest share of the market in 2021. However, the retail stores segment is anticipated to register the highest CAGR during the forecast period.
- Based on age, the enteral medical nutrition market is bifurcated into child (till 18 years) and adult (18+ years). The adult segment (18+ years) held a larger share of the market in 2021. However, the child segment (till 18 years) t is anticipated to register a higher CAGR during the forecast period.
The COVID-19 outbreak pandemic propelled the enteral medical nutrition market growth. Various hospitals in the US administered enteral nutrition to critically ill COVID-19 patients. As per the study ‘Role of Early Enteral Nutrition in Mechanically Ventilated COVID-19 Patients‘ conducted in the US, administration of early EN in critically ill patients led to shorter ICU and hospital stay, liberation from mechanical ventilation, and reduced cost. Thus, the enteral medical nutrition market in North America witnessed growth during the outbreak due to an increased demand for enteral nutrition for COVID-19 patients.
By region, the global enteral medical nutrition market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2021. The enteral medical nutrition market in the region is driven by the increasing prevalence of cancer and COPD, the rising acceptance for the use of enteral medical nutrition for various diseases, and the approval for enteral medical nutrition products.
Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLE S.A.; Meiji Holdings Co., Ltd.; Smartfish AS; DSM; Hormel Foods Corporation; and Global Health Products, Inc. are among the leading companies operating in the global enteral medical nutrition market.
Enteral Medical Nutrition Market, by Region, 2022 (%)
Enteral Medical Nutrition Market Size & Share Analysis by 2028
Download Free SampleEnteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
By geography, the global market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).